Pharmacological Data and Technical Feasibility of Intraperitoneal 5-Fluorouracil Administration
Open Access
- 1 October 1982
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 68 (5) , 437-441
- https://doi.org/10.1177/030089168206800514
Abstract
Via a surgically implanted Tenckhoff catheter, 5-fluorouracil was intraperitoneally administered to patients with malignant disease confined to abdominal space. Treatment was well tolerated without local complications. Peritoneal and plasmatic drug levels were measured, showing that: 1) peritoneal drug levels declined as a first order function; 2) plasmatic levels were very close to those reported for continuous i.v. administration, but peritoneal concentrations were much higher (log 1 to 3); 3) concentration × time product had a peritoneum: plasma ratio ranging from 120 to 1350. The hypothesized role of intraperitoneal 5-fluorouracil administration and the questions still to be answered are summarized.This publication has 8 references indexed in Scilit:
- HIGH-VOLUME INTRAPERITONEAL CHEMOTHERAPY WITH METHOTREXATE IN PATIENTS WITH CANCER1981
- PORTAL LEVELS AND HEPATIC-CLEARANCE OF 5-FLUOROURACIL AFTER INTRAPERITONEAL ADMINISTRATION IN HUMANS1981
- PHASE-I AND PHARMACOLOGICAL STUDIES OF 5-FLUOROURACIL ADMINISTERED INTRAPERITONEALLY1980
- Continuous Ambulatory Peritoneal DialysisAnnals of Internal Medicine, 1978
- PHARMACOKINETIC RATIONALE FOR PERITONEAL DRUG ADMINISTRATION IN TREATMENT OF OVARIAN CANCER1978
- High volume intraperitoneal chemotherapy (?Belly bath?) for ovarian cancerCancer Chemotherapy and Pharmacology, 1978
- The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in manClinical Pharmacology & Therapeutics, 1964
- Hemisulfur Mustard in the Palliation of Patients with Metastatic Ovarian CarcinomaObstetrics & Gynecology, 1959